Literature DB >> 8168153

Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions.

K Motojima1.   

Abstract

The structurally diverse xenobiotic peroxisome proliferators (PPs) increase the number of peroxisomes per cell and the levels of several enzymes, and cause hepatomegaly, often leading to hepatocarcinogenesis in a species- and tissue-specific manner. The deadlocked problems of the molecular mechanism of PP action and its physiological meanings have begun to be understood through cDNA cloning of a PP-activated receptor (PPAR). PPAR, a member of the steroid/thyroid/vitamin superfamily of nuclear receptors, has isoforms and differentially heterodimerizes with other nuclear receptors, providing potential mechanisms not only for species- and tissue-specific actions but also for diverse actions of PPs. Recent findings related to PPAR are summarized, and its possible role in lipid metabolism and involvement in PP-induced hepatocarcinogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8168153     DOI: 10.1247/csf.18.267

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  7 in total

Review 1.  PPARα Between Aspirin and Plaque Clearance.

Authors:  Sujyoti Chandra; Avik Roy; Dhruv R Patel; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Properties of a fluorescent bezafibrate derivative (DNS-X). A new tool to study peroxisome proliferation and fatty acid beta-oxidation.

Authors:  J P Berlot; T Lutz; M Cherkaoui Malki; V Nicolas-Frances; B Jannin; N Latruffe
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

3.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

4.  Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study.

Authors:  Hidekatsu Yanai; Hisayuki Katsuyama; Mariko Hakoshima
Journal:  Biomedicines       Date:  2022-02-08

Review 5.  Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment.

Authors:  Hidekatsu Yanai; Hiroki Adachi; Mariko Hakoshima; Hisayuki Katsuyama
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

Review 6.  Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.

Authors:  Francisco A Monsalve; Radha D Pyarasani; Fernando Delgado-Lopez; Rodrigo Moore-Carrasco
Journal:  Mediators Inflamm       Date:  2013-05-27       Impact factor: 4.711

7.  Cheonggukjang, a soybean paste fermented with B. licheniformis-67 prevents weight gain and improves glycemic control in high fat diet induced obese mice.

Authors:  Joo-Hee Choi; P B Tirupathi Pichiah; Min-Jung Kim; Youn-Soo Cha
Journal:  J Clin Biochem Nutr       Date:  2016-04-29       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.